Their mechanism of action includes binding to CD19-expressing cancer cells, and subsequent activation of downstream signaling pathways through the CD28 and CD3ζ domains, leading to T-cell activation and proliferation, as well as the secretion of inflammatory cytokines and chemokines. The gene discussed is CD19; the disease is cancer.